A
Arnon D. Cohen
Researcher at Clalit Health Services
Publications - 412
Citations - 9549
Arnon D. Cohen is an academic researcher from Clalit Health Services. The author has contributed to research in topics: Population & Odds ratio. The author has an hindex of 41, co-authored 374 publications receiving 7913 citations. Previous affiliations of Arnon D. Cohen include University of Milan & University of Connecticut.
Papers
More filters
Book ChapterDOI
EEG Sleep Staging Using Vectorial Autoregressive Models
TL;DR: Novel algorithms for segmentation, classification and compression of vector EEG are described and the statistics of the suggested measures for segmentations and classification are discussed.
Journal ArticleDOI
Manpower for Engineering Laboratory Courses
Herzl Aharoni,Arnon D. Cohen +1 more
TL;DR: In this paper, two major problems of student laboratory courses are analyzed and discussed: (1) the qualifications and motivations of typical laboratory instructors, and (2) the attitude at the departmental policy-making level towards the laboratory.
Journal ArticleDOI
Dermatoepidemiology; what's up people?
Tamar Nijsten,Christian Apfelbacher,Paolo Gisondi,Jonathan I. Silverberg,Arnon D. Cohen,Sébastien Barbarot,Marlies Wakkee,Khaled Ezzedine +7 more
TL;DR: The exciting aspect of epidemiology is that it is often exploratory and hypothesis generating, however, for observational research to become ‘real’, the findings need to be replicated in other populations, further explained by laboratory research and evaluated by clinical research.
Journal ArticleDOI
Multiple agminated trichodiscomas in the earlobe
TL;DR: This work describes multiple agminated trichodiscomas in the earlobe, which may occur as isolated tumors or in association with other follicular tumors.
Journal ArticleDOI
Dipeptidyl-peptidase IV inhibitor (DPP4i) confers increased odds of bullous pemphigoid even years after drug initiation
Khalaf Kridin,Orly Avni,Giovanni Damiani,Dana Tzur Bitan,Erez Onn,Orly Weinstein,Arnon D. Cohen +6 more
TL;DR: In this paper , the authors investigated the risk of bullous pemphigoid (BP) following exposure to dipeptidyl-peptide IV inhibitors (DPP4i) and performed a duration-response analysis.